KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Return on Equity (2016 - 2025)

Abbott Laboratories' Return on Equity history spans 17 years, with the latest figure at 0.13% for Q4 2025.

  • For Q4 2025, Return on Equity fell 73.0% year-over-year to 0.13%; the TTM value through Dec 2025 reached 0.13%, down 73.0%, while the annual FY2025 figure was 0.13%, 43.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.13% at Abbott Laboratories, down from 0.63% in the prior quarter.
  • Across five years, Return on Equity topped out at 1.25% in Q1 2023 and bottomed at 4.33% in Q2 2025.
  • The 5-year median for Return on Equity is 0.22% (2025), against an average of 0.35%.
  • The largest annual shift saw Return on Equity soared 2079bps in 2021 before it crashed -361bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 1.05% in 2021, then crashed by -154bps to 0.56% in 2022, then plummeted by -147bps to 1.39% in 2023, then soared by 162bps to 0.86% in 2024, then plummeted by -85bps to 0.13% in 2025.
  • Per Business Quant, the three most recent readings for ABT's Return on Equity are 0.13% (Q4 2025), 0.63% (Q3 2025), and 4.33% (Q2 2025).